A detailed history of Davis Investment Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davis Investment Partners, LLC holds 972 shares of VRTX stock, worth $438,595. This represents 0.19% of its overall portfolio holdings.

Number of Shares
972
Previous 4,912 80.21%
Holding current value
$438,595
Previous $2.4 Billion 81.29%
% of portfolio
0.19%
Previous 0.99%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$460.0 - $505.78 $1.81 Million - $1.99 Million
-3,940 Reduced 80.21%
972 $449 Million
Q2 2024

Jul 18, 2024

BUY
$392.81 - $485.53 $225,472 - $278,694
574 Added 13.23%
4,912 $2.4 Billion
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $2,038 - $2,230
5 Added 0.12%
4,338 $1.72 Billion
Q4 2023

Jan 12, 2024

BUY
$343.0 - $410.68 $33,271 - $39,835
97 Added 2.29%
4,333 $1.8 Billion
Q3 2023

Oct 10, 2023

BUY
$338.18 - $362.46 $69,665 - $74,666
206 Added 5.11%
4,236 $1.5 Billion
Q1 2023

Apr 14, 2023

SELL
$283.23 - $323.1 $56,646 - $64,620
-200 Reduced 4.73%
4,030 $1.27 Billion
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $1.21 Million - $1.36 Million
4,230 New
4,230 $1.27 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Davis Investment Partners, LLC Portfolio

Follow Davis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davis Investment Partners, LLC with notifications on news.